Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04491084
Title FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy (FLT3)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Albert Einstein College of Medicine

lung non-small cell carcinoma


CDX-1140 + CDX-301

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST